AEQ Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aequus Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 0.047 EUR

Market Cap: €10.2m

A	Aequus Pharmaceuticals Inc SWB:AEQ	CA
B	BioInfra Co Ltd KOSDAQ:199730	KR
H	Home Concept France SA PAR:MLHCF	FR
	Sure Ventures PLC LSE:SURE	UK
O	OOOOO Entertainment Commerce Ltd XTSX:OOOO	CA

Profitability Summary

Aequus Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

57%

Strong 3Y Average Gross Margin

58%

Declining Gross Margin

82% > 57%

Negative Operating Margin

-62%

Negative 3Y Average Operating Margin

-583%

Operating Margin is Increasing

-315% > -62%

Negative Net Margin

-71%

Negative 3Y Average Net Margin

-630%

Net Margin is Increasing

-322% > -71%

Negative Free Cash Flow Margin

-13%

Negative 3Y Average Free Cash Flow Margin

-499%

Free Cash Flow Margin is Increasing

-187% > -13%

Positive ROE

10%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

652%

ROIC is Increasing

-346% > 227%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.